PlainRecalls
FDA Drug Moderate Class II Terminated

Vumerity (diroximel fumarate) delayed-release capsule, 231 mg, packaged in a) 106-count bottle, b)120-count bottle, Rx only, Manufactured for: Biogen Inc., Cambridge, MA 02142, NDC 64406-020-01

Reported: December 23, 2020 Initiated: December 9, 2020 #D-0148-2021

Product Description

Vumerity (diroximel fumarate) delayed-release capsule, 231 mg, packaged in a) 106-count bottle, b)120-count bottle, Rx only, Manufactured for: Biogen Inc., Cambridge, MA 02142, NDC 64406-020-01

Reason for Recall

Failed dissolution specifications: out-of-specification test results observed during the buffer stage dissolution testing.

Details

Recalling Firm
Biogen MA Inc.
Units Affected
5,307 bottles
Distribution
USA Nationwide
Location
Research Triangle Park, NC

Frequently Asked Questions

What product was recalled?
Vumerity (diroximel fumarate) delayed-release capsule, 231 mg, packaged in a) 106-count bottle, b)120-count bottle, Rx only, Manufactured for: Biogen Inc., Cambridge, MA 02142, NDC 64406-020-01. Recalled by Biogen MA Inc.. Units affected: 5,307 bottles.
Why was this product recalled?
Failed dissolution specifications: out-of-specification test results observed during the buffer stage dissolution testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 23, 2020. Severity: Moderate. Recall number: D-0148-2021.